chadox1 chik
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2018 (NCT03590392)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Chikungunya virusImmunity, active
immunity, active - Chikungunya virus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04440774 | Phase 1 | Oct 23, 2020 | Universidad Autonoma de Nuevo Leon, University of Oxford |
| NCT04015648 | Phase 1 | Jul 1, 2019 | University of Oxford |
| NCT03590392 | Phase 1 | Jul 31, 2018 | University of Oxford |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oxford | Academic/Hospital | 3 | 3 | 1 | 2018 |
| Universidad Autonoma de Nuevo Leon | Academic/Hospital | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1